4.7 Article

Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer

期刊

EBIOMEDICINE
卷 2, 期 7, 页码 681-689

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ebiom.2015.05.009

关键词

Citizen science; Crowd science; Crowdsourcing; Breast cancer

资金

  1. Cancer Research UK
  2. Cancer Research UK [C490/A10124, C490/A16561]
  3. Dutch Cancer Society [NKI 2007-3839, 2009-4363]
  4. NIHR Biomedical Research Centre at the University of Cambridge, Yorkshire Cancer Research [S295, S299, S305PA]
  5. Red Tematica de Investigacion Cooperativa en Cancer
  6. Fondo de Investigacion Sanitario [PI11/00923, PI081120]
  7. Instituto de Salud Carlos III
  8. Baden Wurttemberg Ministry of Science, Research and Arts
  9. Academy of Medical Sciences (AMS) [AMS-SGCL11-Ali] Funding Source: researchfish
  10. Cancer Foundation Finland sr [140141] Funding Source: researchfish
  11. Cancer Research UK [22310, 16561, 16942] Funding Source: researchfish
  12. Cancer Research UK
  13. The Francis Crick Institute [10124] Funding Source: researchfish
  14. National Institute for Health Research [NF-SI-0611-10154, CL-2013-14-006] Funding Source: researchfish

向作者/读者索取更多资源

Background: Citizen science, scientific research conducted by non-specialists, has the potential to facilitate biomedical research using available large-scale data, however validating the results is challenging. The Cell Slider is a citizen science project that intends to share images from tumors with the general public, enabling them to score tumor markers independently through an internet-based interface. Methods: From October 2012 to June 2014, 98,293 Citizen Scientists accessed the Cell Slider web page and scored 180,172 sub-images derived from images of 12,326 tissue microarray cores labeled for estrogen receptor (ER). We evaluated the accuracy of Citizen Scientist's ER classification, and the association between ER status and prognosis by comparing their test performance against trained pathologists. Findings: The area under ROC curve was 0.95 (95% CI 0.94 to 0.96) for cancer cell identification and 0.97 (95% CI 0.96 to 0.97) for ER status. ER positive tumors scored by Citizen Scientists were associated with survival in a similar way to that scored by trained pathologists. Survival probability at 15 years were 0.78 (95% CI 0.76 to 0.80) for ER-positive and 0.72 (95% CI 0.68 to 0.77) for ER-negative tumors based on Citizen Scientists classification. Based on pathologist classification, survival probability was 0.79 (95% CI 0.77 to 0.81) for ER-positive and 0.71 (95% CI 0.67 to 0.74) for ER-negative tumors. The hazard ratio for death was 0.26 (95% CI 0.18 to 0.37) at diagnosis and became greater than one after 6.5 years of follow-up for ER scored by Citizen Scientists, and 0.24 (95% CI 0.18 to 0.33) at diagnosis increasing thereafter to one after 6.7 (95% CI 4.1 to 10.9) years of follow-up for ER scored by pathologists. Interpretation: Crowdsourcing of the general public to classify cancer pathology data for research is viable, engages the public and provides accurate ER data. Crowdsourced classification of research data may offer a valid solution to problems of throughput requiring human input. (C) 2015 The Authors. Published by Elsevier B. V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据